Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
CG Oncology, Inc. Common stock
CGONCurrent price
32.9 USD
-2.94 USD (-8.19%)
Last closed
35.5 USD
Company
–
ISIN
US1569441009
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
2 399 047 168 USD
Yield for 12 month
-11.50 %
1Y
3Y
5Y
10Y
15Y
CGON
CG Oncology, Inc., an oncolytic immunotherapy company, focuses on developing and commercializing backbone bladder-sparing therapeutics for patients with bladder cancer. The company develops BOND-003 for the treatment of high-risk bacillus calmette guerin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) patients; CORE-001 to treat cretostimogene in combination with pembrolizumab in high-risk BCG-unresponsive NMIBC patients; and CORE-002 for the treatment of cretostimogene in combination with the checkpoint inhibitor nivolumab in muscle invasive bladder cancer patients. It also develops PIVOT-006, a cretostimogene monotherapy for intermediate-risk NMIBC following transurethral resection of the bladder tumor; and CORE-008 for treating patients with high-risk NMIBC, including BCG-exposed and BCG-naïve NMIBC patients. CG Oncology, Inc. was formerly known as Cold Genesys, Inc. and changed its name to CG Oncology, Inc. in June 2020. The company was founded in 2010 and is based in Irvine, California. Address: 400 Spectrum Center Drive, Irvine, CA, United States, 92618
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
68.2 USDP/E ratio
–Dividend Yield
–Current Year
+204 000 USD
Last Year
+191 000 USD
Current Quarter
+111 000 USD
Last Quarter
+529 000 USD
Current Year
+187 000 USD
Last Year
+176 000 USD
Current Quarter
+104 000 USD
Last Quarter
+525 000 USD
Key Figures CGON
1 year
3 years
5 years
10 years
EBITDA
-68 180 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
–
PEG Ratio
–
Return On Equity TTM
–
Wall Street Target Price
68.2 USD
Revenue TTM
539 000 USD
Book Value
–
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
172.7 %
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
–
Diluted Eps TTM
–
Most Recent Quarter
I 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics CGON
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History CGON
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation CGON
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
3400.6334
Price Sales TTM
4450.9224
Enterprise Value EBITDA
–
Price Book MRQ
4.2167
Financials CGON
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators CGON
For 52 weeks
25.77 USD
50.23 USD
50 Day MA
35.55 USD
Shares Short Prior Month
6 972 378
200 Day MA
37.93 USD
Short Ratio
4.11
Shares Short
5 957 280
Short Percent
4.27 %
BeatStart